KYMR
Kymera Therapeutics Inc.
$57.87
-$3.97(-6.42%)
63
Overall
60
Value
66
Tech
63
Quality
Market Cap
$4.43B
Volume
625.17K
52W Range
$19.45 - $63.96
Target Price
$67.86
Key Metrics Overview
| Market Cap | $4.43B | P/E Ratio | N/A |
| 52W High | $63.96 | 52W Low | $19.45 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -12.6% | 52W Position | 86.3% |
| Overall Score | 63 | Value Score | 60 |
| Quality Score | 63 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-3.28 | EPS Next Est | $-3.92 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $57.87 | -6.4% | 625.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW